About
Joseph Capobianco is Chief Commercialization Officer of Lytos Technologies, where he leads the translation of breakthrough biology into products customers can trust and adopt. He partners with the Chief Scientific Officer and R&D to shape product direction, convert market learning into practical requirements, and guide pilots that prove value in real operating conditions. Dr. Capobianco is a builder by nature. Across his career, he has launched and scaled technologies in regulated, high-performance markets by turning complex science into reliable, repeatable outcomes. He co-founded TBT Group, Inc. and ACI Materials, bringing innovative advanced materials to market across defense, biomedical, sonar, energy, aerospace, automotive, and electronics. Both companies remain active and commercially successful, and his work has spanned R&D, manufacturing scale-up, quality systems, and business development. He also spent nearly a decade at the USDA Agricultural Research Service (USDA-ARS), lea
Position in the VCSift Database
- • 2 investors hold the Chief Commercialization Officer role in VCSift. Joseph Capobianco is one of them.
- • 2 investors are based in Waynesboro, Virginia, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Waynesboro, US
Contact Information
Find more investors like Joseph
Search Investors